HEADER TRANSCRIPTION 13-DEC-06 2O9I TITLE CRYSTAL STRUCTURE OF THE HUMAN PREGNANE X RECEPTOR LBD IN COMPLEX WITH TITLE 2 AN SRC-1 COACTIVATOR PEPTIDE AND T0901317 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORPHAN NUCLEAR RECEPTOR PXR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PREGNANE X RECEPTOR, ORPHAN NUCLEAR RECEPTOR PAR1, STEROID COMPND 6 AND XENOBIOTIC RECEPTOR, SXR; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1 ISOFORM 3; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: RESIDUES 625-639; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, PXR, T0901317, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,M.R.REDINBO REVDAT 5 30-AUG-23 2O9I 1 REMARK REVDAT 4 20-OCT-21 2O9I 1 REMARK SEQADV REVDAT 3 24-FEB-09 2O9I 1 VERSN REVDAT 2 20-FEB-07 2O9I 1 JRNL REVDAT 1 30-JAN-07 2O9I 0 JRNL AUTH Y.XUE,E.CHAO,W.J.ZUERCHER,T.M.WILLSON,J.L.COLLINS, JRNL AUTH 2 M.R.REDINBO JRNL TITL CRYSTAL STRUCTURE OF THE PXR-T1317 COMPLEX PROVIDES A JRNL TITL 2 SCAFFOLD TO EXAMINE THE POTENTIAL FOR RECEPTOR ANTAGONISM. JRNL REF BIOORG.MED.CHEM. V. 15 2156 2007 JRNL REFN ISSN 0968-0896 JRNL PMID 17215127 JRNL DOI 10.1016/J.BMC.2006.12.026 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1172964.080 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 20118 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1029 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3134 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4793 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 67.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.01000 REMARK 3 B22 (A**2) : -1.86000 REMARK 3 B33 (A**2) : -2.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.630 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.890 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.170 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 38.64 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : 444.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : 444.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2O9I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040856. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20332 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09400 REMARK 200 FOR THE DATA SET : 25.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28100 REMARK 200 FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ILG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM IMIDIZOLE, 10% 2-PROPANOL (V/V), REMARK 280 PH 7.1, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.98950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.86250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.30900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.86250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.98950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.30900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 434 REMARK 465 SER B 1179 REMARK 465 SER B 1180 REMARK 465 GLY B 1181 REMARK 465 CYS B 1182 REMARK 465 GLU B 1183 REMARK 465 LEU B 1184 REMARK 465 PRO B 1185 REMARK 465 GLU B 1186 REMARK 465 SER B 1187 REMARK 465 LEU B 1188 REMARK 465 GLN B 1189 REMARK 465 ALA B 1190 REMARK 465 PRO B 1191 REMARK 465 SER B 1434 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 270 OE1 GLN A 316 3545 1.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 144 170.20 -58.51 REMARK 500 ASN A 171 38.46 70.69 REMARK 500 VAL A 177 33.93 -98.24 REMARK 500 CYS A 207 -84.23 -42.32 REMARK 500 SER A 208 39.71 -85.87 REMARK 500 SER A 231 169.07 166.84 REMARK 500 LYS A 234 -26.52 -28.24 REMARK 500 ILE A 269 -38.00 -35.90 REMARK 500 CYS A 301 66.69 -113.39 REMARK 500 ALA A 312 142.60 -33.73 REMARK 500 PHE A 315 -70.01 -41.44 REMARK 500 GLN A 334 64.61 30.16 REMARK 500 PRO A 351 3.55 -65.18 REMARK 500 PRO A 384 -16.84 -44.84 REMARK 500 PHE A 388 -5.95 80.17 REMARK 500 PHE A 420 -28.03 -158.51 REMARK 500 ALA A 421 151.42 -45.83 REMARK 500 ILE A 431 97.57 -62.49 REMARK 500 THR A 432 -45.28 -4.82 REMARK 500 PHE B1166 14.32 57.68 REMARK 500 ARG B1193 -73.40 -74.91 REMARK 500 GLU B1194 -61.05 -3.62 REMARK 500 GLU B1195 47.58 -103.95 REMARK 500 PRO B1228 -152.13 -67.56 REMARK 500 SER B1231 178.01 155.80 REMARK 500 LYS B1234 13.93 -61.51 REMARK 500 GLU B1235 17.54 -68.32 REMARK 500 ILE B1269 -23.85 -38.11 REMARK 500 CYS B1301 59.59 -107.20 REMARK 500 GLU B1309 41.23 -97.69 REMARK 500 ASP B1310 76.77 -9.18 REMARK 500 THR B1311 -158.70 -61.85 REMARK 500 ALA B1312 -102.51 -39.39 REMARK 500 ASP B1352 27.35 -68.89 REMARK 500 LEU B1357 -62.68 -103.32 REMARK 500 GLN B1358 35.83 -64.64 REMARK 500 HIS B1359 -4.36 -52.34 REMARK 500 GLN B1383 128.68 -21.35 REMARK 500 PHE B1420 -30.79 -161.22 REMARK 500 PHE B1429 -64.65 -98.85 REMARK 500 ILE B1431 41.58 -70.91 REMARK 500 HIS C 630 59.80 -143.18 REMARK 500 LYS C 631 -76.78 -48.05 REMARK 500 ARG D1629 33.89 -93.32 REMARK 500 HIS D1630 36.43 -144.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 A 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SKX RELATED DB: PDB REMARK 900 RELATED ID: 1NRL RELATED DB: PDB REMARK 900 RELATED ID: 1ILG RELATED DB: PDB REMARK 900 RELATED ID: 1ILH RELATED DB: PDB REMARK 900 RELATED ID: 1M13 RELATED DB: PDB DBREF 2O9I A 142 434 UNP O75469 PXR_HUMAN 142 434 DBREF 2O9I B 1142 1434 UNP O75469 PXR_HUMAN 1142 1434 DBREF 2O9I C 625 639 PDB 2O9I 2O9I 625 639 DBREF 2O9I D 1625 1639 PDB 2O9I 2O9I 1625 1639 SEQADV 2O9I SER A 284 UNP O75469 CYS 284 ENGINEERED MUTATION SEQADV 2O9I SER B 1284 UNP O75469 CYS 284 ENGINEERED MUTATION SEQRES 1 A 293 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU SEQRES 2 A 293 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER SEQRES 3 A 293 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER SEQRES 4 A 293 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG SEQRES 5 A 293 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU SEQRES 6 A 293 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP SEQRES 7 A 293 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY SEQRES 8 A 293 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP SEQRES 9 A 293 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA SEQRES 10 A 293 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP SEQRES 11 A 293 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU SER SEQRES 12 A 293 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY SEQRES 13 A 293 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP SEQRES 14 A 293 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET SEQRES 15 A 293 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS SEQRES 16 A 293 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE SEQRES 17 A 293 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL SEQRES 18 A 293 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER SEQRES 19 A 293 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE SEQRES 20 A 293 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG SEQRES 21 A 293 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE SEQRES 22 A 293 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU SEQRES 23 A 293 LEU PHE GLY ILE THR GLY SER SEQRES 1 B 293 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU SEQRES 2 B 293 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER SEQRES 3 B 293 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER SEQRES 4 B 293 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG SEQRES 5 B 293 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU SEQRES 6 B 293 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP SEQRES 7 B 293 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY SEQRES 8 B 293 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP SEQRES 9 B 293 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA SEQRES 10 B 293 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP SEQRES 11 B 293 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU SER SEQRES 12 B 293 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY SEQRES 13 B 293 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP SEQRES 14 B 293 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET SEQRES 15 B 293 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS SEQRES 16 B 293 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE SEQRES 17 B 293 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL SEQRES 18 B 293 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER SEQRES 19 B 293 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE SEQRES 20 B 293 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG SEQRES 21 B 293 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE SEQRES 22 B 293 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU SEQRES 23 B 293 LEU PHE GLY ILE THR GLY SER SEQRES 1 C 15 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 2 C 15 GLN GLU SEQRES 1 D 15 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 2 D 15 GLN GLU HET 444 A 2 31 HET 444 B 1 31 HETNAM 444 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1- HETNAM 2 444 HYDROXY-1-(TRIFLUOROMETHYL) HETNAM 3 444 ETHYL]PHENYL}BENZENESULFONAMIDE FORMUL 5 444 2(C17 H12 F9 N O3 S) FORMUL 7 HOH *135(H2 O) HELIX 1 1 THR A 144 PHE A 162 1 19 HELIX 2 2 ARG A 193 LEU A 206 1 14 HELIX 3 3 CYS A 207 LEU A 209 5 3 HELIX 4 4 GLY A 233 SER A 238 5 6 HELIX 5 5 LEU A 239 ILE A 261 1 23 HELIX 6 6 ILE A 261 ASP A 266 1 6 HELIX 7 7 PRO A 268 VAL A 291 1 24 HELIX 8 8 GLY A 314 LEU A 319 1 6 HELIX 9 9 GLU A 321 LEU A 333 1 13 HELIX 10 10 HIS A 336 PHE A 349 1 14 HELIX 11 11 GLN A 358 ARG A 381 1 24 HELIX 12 12 GLN A 383 ARG A 387 5 5 HELIX 13 13 PHE A 388 HIS A 418 1 31 HELIX 14 14 THR A 422 GLY A 430 1 9 HELIX 15 15 THR B 1144 PHE B 1162 1 19 HELIX 16 16 ALA B 1196 SER B 1208 1 13 HELIX 17 17 LEU B 1239 VAL B 1260 1 22 HELIX 18 18 ILE B 1261 ASP B 1266 1 6 HELIX 19 19 PRO B 1268 THR B 1290 1 23 HELIX 20 20 GLY B 1314 LEU B 1319 1 6 HELIX 21 21 GLU B 1321 LEU B 1333 1 13 HELIX 22 22 HIS B 1336 PHE B 1349 1 14 HELIX 23 23 GLN B 1358 ARG B 1381 1 24 HELIX 24 24 GLN B 1383 ARG B 1387 5 5 HELIX 25 25 PHE B 1388 HIS B 1418 1 31 HELIX 26 26 THR B 1422 GLY B 1430 1 9 HELIX 27 27 HIS C 630 GLN C 638 1 9 HELIX 28 28 HIS D 1630 GLU D 1639 1 10 SHEET 1 A10 PHE A 292 ASN A 293 0 SHEET 2 A10 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 A10 LEU A 304 LEU A 308 -1 O TYR A 306 N TRP A 299 SHEET 4 A10 VAL A 211 ARG A 216 -1 N SER A 212 O CYS A 307 SHEET 5 A10 VAL A 222 LYS A 226 -1 O TRP A 223 N LEU A 215 SHEET 6 A10 VAL B1222 LYS B1226 -1 O VAL B1222 N LYS A 226 SHEET 7 A10 VAL B1211 ARG B1216 -1 N LEU B1213 O TYR B1225 SHEET 8 A10 LEU B1304 LEU B1308 -1 O CYS B1307 N SER B1212 SHEET 9 A10 THR B1298 CYS B1301 -1 N TRP B1299 O TYR B1306 SHEET 10 A10 PHE B1292 ASN B1293 -1 N ASN B1293 O THR B1298 SITE 1 AC1 15 LEU B1206 LEU B1209 MET B1243 SER B1247 SITE 2 AC1 15 GLN B1285 PHE B1288 TRP B1299 TYR B1306 SITE 3 AC1 15 MET B1323 LEU B1324 HIS B1327 HIS B1407 SITE 4 AC1 15 LEU B1411 ILE B1414 PHE B1420 SITE 1 AC2 15 LEU A 209 VAL A 211 LEU A 240 MET A 243 SITE 2 AC2 15 MET A 246 GLN A 285 PHE A 288 TRP A 299 SITE 3 AC2 15 TYR A 306 LEU A 308 HIS A 327 HIS A 407 SITE 4 AC2 15 LEU A 411 PHE A 420 MET A 425 CRYST1 83.979 90.618 105.725 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011908 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009459 0.00000